Severe Liver Disease Related to Chronic Hepatitis C Virus Infection in Treatment-Naive Patients: Epidemiological Characteristics and Associated Factors at First Expert Centre Visit, France, 2000 to 2007 and 2010 to 2014

作者: Alice Sanna , Yann Le Strat , Françoise Roudot-Thoraval , Sylvie Deuffic Burban , Patrizia Carrieri

DOI: 10.2807/1560-7917.ES.2017.22.30.30582

关键词:

摘要: Given recent profound improvements in the effectiveness of antiviral treatment for chronic Hepatitis C virus (HCV) infection, we aimed to describe characteristics patients referred hepatology expert centres France from 2000 2007 and 2010 2014, identify factors associated with severe liver disease at their first visit evaluation. We analysed data two sources covering all France: former hepatitis surveillance network, which included between 2007, ANRS CO22 HEPATHER multi-centre cohort, 2012 2014. Severe (SLD) was defined as presence either cirrhosis (histological, biochemical or clinical) hepatocellular carcinoma. Multivariable Poisson regression models were used SLD complete-case analysis after multiple imputation. Overall, 16,851 diagnosed 11.6%. significantly known risk (male sex, history excessive alcohol intake, HCV genotype 3), late referral hepatologists diagnosis an older age. Providing earlier specialised care may be important target public health action.

参考文章(33)
Rachel H. Westbrook, Geoffrey Dusheiko, Natural history of hepatitis C Journal of Hepatology. ,vol. 61, pp. S58- S68 ,(2014) , 10.1016/J.JHEP.2014.07.012
W. Chen, M. Krahn, Disease burden of chronic hepatitis C among immigrants in Canada. Journal of Viral Hepatitis. ,vol. 22, pp. 1043- 1054 ,(2015) , 10.1111/JVH.12432
Tim P. Morris, Ian R. White, James R. Carpenter, Simon J. Stanworth, Patrick Royston, Combining fractional polynomial model building with multiple imputation. Statistics in Medicine. ,vol. 34, pp. 3298- 3317 ,(2015) , 10.1002/SIM.6553
Jean-Michel Pawlotsky, Francesco Negro, Alessio Aghemo, Marina Berenguer, Olav Dalgard, Geoffrey Dusheiko, Fiona Marra, Massimo Puoti, Heiner Wedemeyer, EASL Recommendations on Treatment of Hepatitis C 2018 Journal of Hepatology. ,vol. 69, pp. 461- 511 ,(2018) , 10.1016/J.JHEP.2018.03.026
Julie Bottero, Cécile Brouard, Françoise Roudot-Thoraval, Sylvie Deuffic-Burban, Philippe Hofliger, Armand Abergel, Johann Volant, Daniel Dhumeaux, Yazdan Yazdanpanah, , 2014 French guidelines for hepatitis B and C screening.A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV Liver International. ,vol. 36, pp. 1442- 1449 ,(2016) , 10.1111/LIV.13135
Steffen Zopf, Andreas E Kremer, Markus F Neurath, Juergen Siebler, Advances in hepatitis C therapy: What is the current state - what come's next? World Journal of Hepatology. ,vol. 8, pp. 139- 147 ,(2016) , 10.4254/WJH.V8.I3.139
Stanislas Pol, Marc Bourliere, Sandy Lucier, Christophe Hezode, Céline Dorival, Dominique Larrey, Jean-Pierre Bronowicki, Victor DE Ledinghen, Fabien Zoulim, Albert Tran, Sophie Metivier, Jean-Pierre Zarski, Didier Samuel, Dominique Guyader, Patrick Marcellin, Anne Minello, Laurent Alric, Dominique Thabut, Olivier Chazouilleres, Ghassan Riachi, Valérie Bourcier, Philippe Mathurin, Véronique Loustaud-Ratti, Louis D’alteroche, Isabelle Fouchard-Hubert, François Habersetzer, Xavier Causse, Claire Geist, Isabelle Rosa, Jérôme Gournay, Eric Saillard, Eric Billaud, Ventzislava Petrov-Sanchez, Alpha Diallo, Helene Fontaine, Fabrice Carrat, ANRS/AFEF HEPATHER study group, Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. Journal of Hepatology. ,vol. 66, pp. 39- 47 ,(2017) , 10.1016/J.JHEP.2016.08.021
Evangelista Sagnelli, , Tommaso Stroffolini, Caterina Sagnelli, Mario Pirisi, Sergio Babudieri, Guido Colloredo, Maurizio Russello, Nicola Coppola, Giovanni Battista Gaeta, Bruno Cacopardo, Massimo De Luca, Piero Luigi Almasio, Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy Infection. ,vol. 46, pp. 93- 101 ,(2018) , 10.1007/S15010-017-1101-5